Quantifying the impact of regional variations in COVID-19 infections and hospitalizations across IrelandCovid-19 Published on 2022-02-162022-11-01 Journal: The European Journal of Public Health [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] 95% CI affected analyzed available data collected confidence interval confirmed case COVID-19 case COVID-19 infection COVID-19 outbreak COVID-19 transmission deviation effort Europe exceeded Frequency highest Hospital admission Hospitalization hospitalizations incidence Infection Ireland laboratory-confirmed likelihood Local management measure National nine occur organization protection regions reported response Result risk risk of infection service Surveillance Transmission Variation [DOI] 10.1093/eurpub/ckab173 PMC 바로가기 [Article Type] Covid-19
Registry Systems for COVID-19 Vaccines and Rate of Acceptability for Vaccination Before and After Availability of Vaccines in 12 Countries: A Narrative ReviewReview Published on 2022-02-112022-10-30 Journal: Infectious Disease Reports [Category] COVID-19, [키워드] acceptability Arabic available data Canada country Coverage COVID-19 COVID-19 vaccine dose Emirate Epi functional General population help highest initial narrative Outbreaks pandemic performed Program Randomized Rate Region registry registry systems reported review selected South Africa System vaccination Vaccine Vaccines WHO [DOI] 10.3390/idr14010016 PMC 바로가기 [Article Type] Review
Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative미국 국립 COVID 코호트 공동 연구에서 어린이의 SARS-CoV-2 감염과 관련된 특성, 결과 및 심각도 위험 요소Multicenter Study Published on 2022-02-082022-09-10 Journal: JAMA Network Open [Category] COVID19(2023년), MERS, SARS, 변종, [키워드] 95% CI acute COVID-19 Admission assist available data change Characteristics children children with MIS-C chronic condition Clinical data clinical outcomes clinical phenotype cohort study Comorbidity complex conducted COVID criteria death Delta demographic characteristics disease disease severity element ERAS extracorporeal membrane oxygenation Factor finding granular Hospitalization Hospitalized Illness severity Importance incidence Inflammatory initial invasive ventilation knowledge Laboratory Laboratory test lack Male sex measure mechanical ventilation median age MIS-C multicenter obesity objective Odds ratio outcome outcomes participant pediatric Point positive Predictive preexisting comorbidities prospective cohort study Relevance Result risk risk factor Risk factors SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 testing SARS-CoV-2–positive setting severe disease severity Sex subgroups Support syndrome test results tested Trajectories translate understanding utility variable variant vital sign vital signs [DOI] 10.1001/jamanetworkopen.2021.43151 PMC 바로가기 [Article Type] Multicenter Study
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysisCovid-19에 대한 3 가지 새로운 경구 항 바이러스 처리 (Molnupiravir, Fluvoxamine 및 Paxlovid)의 효능 및 안전성 ： 메타 분석Meta-Analysis Published on 2022-02-042022-09-10 Journal: Annals of Medicine [Category] COVID19(2023년), Fulltext, SARS, 치료제, [키워드] (molnupiravir 95% confidence interval addition adverse event adverse events Antiviral antiviral drug antiviral drugs Antiviral treatment antivirals article available data Cochrane Library conducted control group coronavirus coronavirus disease COVID-19 COVID-19 patient COVID-19 patients COVID-19 research died drug effective eight Epidemic evaluate exhibiting fluvoxamine Guidance Hospitalization Hospitalized Meta-analysis molnupiravir Mortality Occurrence Odds ratio Patient patients with COVID-19 Paxlovid Paxlovid™ placebo group reduced reducing Result retrieved screened searched shown therapeutic effect therapeutic effects treatment for COVID-19 Web of Science [DOI] 10.1080/07853890.2022.2034936 PMC 바로가기 [Article Type] Meta-Analysis
COVID-19 and Mitochondrial Non-Coding RNAs: New Insights From Published DataPhysiology Published on 2022-02-042022-10-31 Journal: Frontiers in Physiology [Category] COVID-19, [키워드] affected Analysis available data cause Cohort COVID COVID-19 dysfunction Effect expression fatigue individual Infection insight investigated involved Long COVID long non-coding RNA metabolism Mitochondria mitochondrial mitochondrial dysfunction mitochondrial metabolism mitochondrial RNA New non-coding RNA Non-coding RNAs Patient Prevent recovering from COVID-19 Research researcher SARS-CoV-2 SARS-COV-2 infection scientist Small RNAs Symptom syndrome the SARS-CoV-2 Transcription treat [DOI] 10.3389/fphys.2021.805005 PMC 바로가기 [Article Type] Physiology
Composition, Clinical Efficiency, and Mechanism of NHC-Approved “Three Chinese Medicines and Three Chinese Recipes” for COVID-19 TreatmentPharmacology Published on 2022-02-042022-10-31 Journal: Frontiers in Pharmacology [Category] COVID-19, [키워드] Analysis approved Asian available data Baidu China Chinese clinical Clinical efficacy clinical study coronavirus disease Coronaviruses COVID-19 COVID-19 infection demonstrated disease Disease progression Effect effective Epidemic evaluate Evidence granules in vitro in vivo Infectious disease lack mechanism Medicine metabolomics molecular docking mortality rate MOST National Health Commission network pharmacology NHC potential mechanism predicted Prevent proteomics reducing san-yao san-fang significant effect Symptoms TCM three Chinese medicine and three Chinese recipes Traditional Chinese medicine traditional Chinese medicine (TCM) treat Treatment were used [DOI] 10.3389/fphar.2021.781090 PMC 바로가기 [Article Type] Pharmacology
Analytical observational study evaluating global pandemic preparedness and the effectiveness of early COVID-19 responses in Ethiopia, Nigeria, Singapore, South Korea, Sweden, Taiwan, UK and USAObservational Study Published on 2022-02-022022-10-05 Journal: BMJ Open [Category] COVID19(2023년), SARS, 임상, [키워드] analysed Analysis approach available data confounder Contact tracing contributed correlated country COVID-19 COVID-19 pandemic death deaths demographics dimensions effective Effectiveness Factor global pandemic Government healthcare implementation Inference influences on Intervention Isolation lack Nigeria outcome pandemic proportion public health resource resources response responses SARS-CoV-2 virus severity significantly Singapore South Korea Spread Surveillance Taiwan Threats USA Variation was measured were used while [DOI] 10.1136/bmjopen-2021-053374 PMC 바로가기 [Article Type] Observational Study
mRNA Covid-19 vaccines in pregnancy: A systematic reviewResearch Article Published on 2022-02-022022-10-28 Journal: PLoS ONE [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] adverse event adverse events Adverse reaction antibody Antibody Response antibody transfer article available data booster clinical Cochrane Library conducted Coronavirus disease 2019 criteria database described develop dose elicit European fatigue fetal first vaccination FIVE headache IgG infection rate injection interval investigated latency Local manual Moderna mRNA mRNA vaccine mRNA vaccines mRNA-based vaccine objective observational study Pain Pfizer–BioNTech Pregnancy pregnant women Prevent registry reported Research responses Result risk factor robust Safe SARS-CoV-2 SARS-COV-2 infection searched Seven suggested systematic review systemic adverse events the WHO union vaccination Vaccine vaccine dose were excluded [DOI] 10.1371/journal.pone.0261350 PMC 바로가기 [Article Type] Research Article
Prevention of host-to-host transmission by SARS-CoV-2 vaccinesSARS-CoV-2 백신에 의한 숙주 간 전파 방지Review Published on 2022-02-012022-09-12 Journal: The Lancet. Infectious Diseases [Category] Fulltext, MERS, 진단, [키워드] approved available data clinical trial Course distribution droplets Effect immunological individual individuals Infection infection with SARS-CoV-2 intramuscular less limit mechanisms mucosa observational study Particle population-level effect prevention Primary infection Randomised trial reduce reducing Replication respiratory epithelia SARS-CoV-2 SARS-CoV-2 vaccine shown symptomatic the vaccine titre Transmissibility Transmission Vaccine viral replication [DOI] 10.1016/S1473-3099(21)00472-2 PMC 바로가기 [Article Type] Review
Immune interventions in COVID-19: a matter of time?COVID-19에 대한 면역 개입: 시간 문제입니까?Review Published on 2022-02-012022-09-11 Journal: Mucosal Immunology [Category] COVID19(2023년), SARS, 임상, 치료제, [키워드] administration animal model animal models Antiviral strategies antiviral strategy available data beta-coronavirus clinical trial clinical trials COVID-19 pandemic discrepancies dysregulated immune response Effect effective Efficacy Frame heterogeneity hyperinflammation immune immune response immunosuppressive drug Infection infections Intervention Kinetics lack Patient Pneumonia reactive required severe COVID-19 the timing Time frame timepoint tissue lesion tissue lesions Treatment [DOI] 10.1038/s41385-021-00464-w PMC 바로가기 [Article Type] Review